Regenerative Medicine Foundation

SUPPORTING REGENERATIVE MEDICINE

Our mission is to accelerate regenerative medicine to improve health and deliver cures

WSCS-RME Registration Opens
February 15, 2021

previous arrow
next arrow
Slider
Regenerative Medicine

Regenerative Medicine

A new paradigm of medicine that relies on stem cells capacity to regenerate, regrow, and fully heal damaged tissues and organs in our bodies.
Ethics and Policy

Ethical Advancement

We are committed to the ethical advancement of an innovative medicine powered by regenerative, restorative, and curative technologies.
Improving Health

Improve Health

All we do is in service of health, life, and the alleviation of human suffering.
Deliver Cures

Deliver Cures

Alleviating the suffering and restoring the hope of patients, and of their loved ones, is what fuels our passion and our work.

Latest News, Opinions and Video

Alliance for Cell Therapy Now Commends Congress for Regenerative Medicine and Cell Therapy Provisions in FY 2021 Spending Bill: Additional Support for Clinical Trials for COVID Patients is Still Needed

Alliance for Cell Therapy Now Commends Congress for Regenerative Medicine and Cell Therapy Provisions in FY 2021 Spending Bill: Additional Support for Clinical Trials for COVID Patients is Still Needed

Washington, DC (December 30, 2020) – Leaders of Alliance for Cell Therapy Now (ACT Now)—including representatives of academic and medical institutions, industry innovators, and patients—applaud Congress for its inclusion of important provisions in the final FY 2021...

FDA Grants Fast Track Designation For Remestemcel-L in the Treatment of Acute Respiratory Distress Syndrome due to Covid-19

Melbourne, Australia; December 2 and New York; USA; December 1, 2020: Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular...

Pre-treating progenitor cells with protein-activator slows progression of atherosclerosis

Durham, NC – A new treatment for atherosclerosis, commonly known as hardening of the arteries, may be on the horizon, according to a study released...

Creating a New Vision – Patient Advocate Kristin MacDonald Shares her Story

RMF's Bernie Siegel celebrates the passing of California Prop 14 with patient advocate Kristin MacDonald, who was instrumental in publicly...

California Voters Deliver a Victory for Proposition 14 

The Passage of Proposition 14 Underscores Californians’ Commitment to Continue Investments in the Discovery of Groundbreaking Treatments and Cures...

Portraits of Hope – Jay Feinberg, Gift of Life Marrow Registry

RMF's Bernie Siegel welcomes Jay Feinberg, founder and CEO of the Gift of Life Marrow Registry, to share his inspiring story, which began in 1991 as...

Prop 14 – The California Stem Cell Initiative: Closing Argument

CALIFORNIA PROPOSITION 14: "The Stem Cell Initiative" webinar was held on Oct 21, 2020. This event was organized by patient advocacy group SUMMIT...

Former NFL Players Show Interest in Regenerative Medicine and Cell Therapies

Mount Laurel, New Jersey, October 14, 2020 – The National Football League Alumni Association (NFLA) today released a report exploring the interest...

Dr. Wenchun Qu discusses the use of MSCs for pain and rehabilitation, mortality reduction for ARDS

RMF's Bernie Siegel welcomes Dr. Wenchun Qu, Center for Regenerative Medicine at the Mayo Clinic in Jacksonville, Florida, a specialist in pain...

Stem Cells And The Transformative Power Of Hope

Dear Friends and Colleagues, Developing a safe and effective pathway for regenerative cell therapies requires a deep understanding of the workings...

Study shows how amniotic fluid might yield new, better treatment for ischemic stroke

Durham, NC – A study released today in STEM CELLS Translational Medicine points the way to a possible new avenue of treatment for ischemic stroke....

Working with Policy Leaders in the United States

Making safe and effective treatments available for patients

Regenerative cellular therapies represent the next generation of groundbreaking treatments that are showing great promise in cardiology, neurology, oncology, orthopedics, ophthalmology, and other areas. Several well-designed clinical trials are being conducted under FDA investigational new drug (IND) protocols. At the same time, a handful of clinics have caused patient harm or made questionable claims, taking advantage of vulnerable patients and casting a negative light on this emerging science and industry.
Marks-Patterson-Siegel-and-Marchibroda Washington DC Policy Meeting
Regenerative Medicine Foundation Logo

What We Do

Conferences

We Produce the World Stem Cell Summit, the RegMed Capital Conference, the Stem Cell Action Awards, and other events.

Patient Advocacy

We inform, celebrate and mobilize the global advocacy movement consisting of patients, advocates and medical philanthropies, all supporting regenerative medicine, including stem cell research and cell therapies.

Policy

Since 2003 we have a track record fostering a supportive regulatory and societal framework for regenerative medicine.

Outreach

We educate the scientific community, public and media through our official, peer-reviewed, journal partner STEM CELLS Translational Medicine, the Regenerative Medicine Weekly Newsletter, social media channels, speaking engagements and media interviews.

A Trusted Network

Regenerative Medicine Foundation unites the world’s leading researchers, medical centers, universities, labs, businesses, funders, policymakers, experts in law, regulation and ethics, medical philanthropies, and patient organizations.
The Regenerative Medicine Foundation is a non-profit organization, granted tax-exempt status under Section 501(c)(3) of the United States Internal Revenue Code. Contributions are tax-deductible to the extent allowable by law.

Join Our Mailing List

Pin It on Pinterest